Sarepta Therapeutics
SRPT
#4401
Rank
HK$18.15 B
Marketcap
HK$173.22
Share price
-2.45%
Change (1 day)
-82.37%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$16.91 Billion

According to Sarepta Therapeutics 's latest financial reports the company's total liabilities are HK$16.91 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sarepta Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$18.90 B0.65%
2023-12-31HK$18.78 B-12.36%
2022-12-31HK$21.43 B23.83%
2021-12-31HK$17.31 B0.45%
2020-12-31HK$17.23 B120.25%
2019-12-31HK$7.82 B63.85%
2018-12-31HK$4.77 B17.82%
2017-12-31HK$4.05 B497.91%
2016-12-31HK$0.67 B4.82%
2015-12-31HK$0.64 B75.97%
2014-12-31HK$0.36 B6.8%
2013-12-31HK$0.34 B-45.4%
2012-12-31HK$0.63 B247.52%
2011-12-31HK$0.18 B-52.24%
2010-12-31HK$0.37 B34.55%
2009-12-31HK$0.28 B272.51%
2008-12-31HK$75.76 M-20.72%
2007-12-31HK$95.56 M289.96%
2006-12-31HK$24.5 M15.02%
2005-12-31HK$21.3 M21.87%
2004-12-31HK$17.48 M-39.87%
2003-12-31HK$29.07 M-27.21%
2002-12-31HK$39.94 M56.13%
2001-12-31HK$25.58 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
HK$288.52 B 1,606.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
HK$10.40 B-38.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
HK$1.92 B-88.59%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
HK$6.49 B-61.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$35.93 B 112.48%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
HK$21.78 B 28.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
HK$11.01 B-34.88%๐Ÿ‡บ๐Ÿ‡ธ USA